Whether lithium inhibits glycogen synthase kinase (GSK)-3β activity in vivo in humans is still an open question

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish
Pages (from-to)464-467
Number of pages4
JournalBipolar Disorders
Issue number5
StatePublished - 1 Aug 2016


  • bipolar disorder
  • glycogen synthase kinase (GSK)-3β
  • lithium
  • therapeutic mechanism

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this